Liposomal Iloprost

N/A

Report date: 2025/12/11 17:56:17

Base Information

Drug NameLiposomal Iloprost
Drug Alias NameL608L-608
ClassificationSmall molecules
Mechanisms of ActionProstanoid receptor agonists
TargetsProstanoid receptor
Therapy Area/IndicationsPulmonary Arterial Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNew ZealandAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPharmosa Biopharm Inc
China Registration ClassN/A

Develop Information

Active CompaniesPharmosa Biopharm Inc
Inactive CompaniesN/A
Active IndicationsPulmonary Arterial Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A